Back to mobile site

Jefferies Affirms Buy Rating for Lumexa Imaging (LMRI) Following Site Visit

April 14, 2026 3:10 PM EDT Send to a Friend
Jefferies analyst Brian Tanquilut reiterated a Buy rating and $23.00 price target on Lumexa Imaging Holdings (NASDAQ: LMRI)The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login